PDL BIOPHARMA, INC. PDLI Cash Flow

Pdl biopharma, inc. (PDLI)

CashFlow / Quarterly

Mar'20	Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14	Dec'13	Sep'13	Jun'13	Mar'13	Dec'12	Sep'12	Jun'12	Mar'12	Dec'11	Sep'11	Jun'11	Mar'11	Dec'10	Sep'10	Jun'10	Mar'10
Cash flows from operating activities
Noncash or Part Noncash Acquisition, Other Assets Acquired
-	-	-	-	-	-	-	-	-	-	-	-	868	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest
-32,011	-54,828	-17,966	-4,514	6,617	16,279	25,556	-112,296	1,602	22,336	20,732	60,439	7,194	-10,280	13,904	4,148	55,887	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Less: (Loss) income from discontinued operations
-244	-	-	-	15,069	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest
-31,767	-	-	-	-8,452	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net income
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	78,264	84,498	-	102,235	92,055	72,883	61,092	56,225	93,742	53,471	49,408	48,575	73,502	40,184	38,942	45,916	69,986	44,545	-24,460	40,189	50,138	26,007
Adjustments to reconcile net loss to net cash used in operating activities:
Amortization of convertible notes conversion option and debt issuance costs
280	1,461	1,900	1,953	1,923	1,864	1,834	1,779	2,132	2,843	2,801	2,719	2,675	3,942	2,048	1,558	2,461	3,219	2,534	3,144	4,066	5,223	3,905	4,751	4,817	3,399	3,369	3,301	3,251	1,974	3,286	3,553	3,668	-	-	-	-	472	283	426	501
Accreted interest on convertible note principal
33	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Amortization of intangible assets
302	1,555	1,575	2,852	318	-	-	-	-	-	-	-	6,015	5,986	6,014	0	0	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-
Amortization of right-of-use assets
185	224	221	288	153	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Amortization of Acquisition Costs
-	-	-	-	-	-	-	-	6,293	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Change in fair value of acquired royalty rights
-	-	-	-	-	-19,139	-42,184	-12,842	-11,091	-30,103	-35,353	-83,725	-13,146	-28,068	-16,085	855	27,102	-49,069	4,280	-12,216	-11,362	28,065	-27,602	-33,683	-11,707	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Change in fair value of equity affiliate
-11,334	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Change in fair value of derivative assets
-2,453	-	-	-	-33	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Change in Unrealized Gain (Loss)
-	-	-	-	-	-81	40	3	71	-20	-165	36	100	-31	-128	-418	-329	985	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability
-	-	-	-	-	-19,198	302	-22,135	-600	-3,000	700	1,207	1,442	-5,799	2,083	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Amortization of non-recourse notes offering costs
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1,671	1,842	1,844	1,881
Other amortization and depreciation
509	606	646	822	827	635	1,033	1,024	1,004	888	887	525	66	2	3	4	9	11	9	10	10	10	-50	-49	-45	-44	-146	-264	50	-	-	-	-	-	-	-	-	-	-	-	-
Other amortization and depreciation expense
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	114	37	34
Gain (Loss) on Extinguishment of Debt
-606	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-6,143	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-
Discounts and deferred issuance costs
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	3,266	2,032	2,044	-	-	-	-
Other amortization, depreciation and accretion of embedded derivative
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	218	288	298	-	363	356	313	-	-	-	-
Hedge ineffectiveness on foreign exchange contracts
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	2	1	2	2	4	2	3	-	-	-	-	-	-	-	-	-	-	-	-
Gain (Loss) on Sale of Investments
-	-	-	-	-	0	0	0	764	0	15	49	44	1	0	745	136	417	580	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Stock-based compensation expense
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	166	171	188
Loss on disposal of property and equipment
-300	-1,200	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Inventory Write-down
-	-	-	-	-	-	-	-	114	1,970	-131	49	112	342	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Provision for bad debts
50	-	-16	-7	0	-	-43	55	-12	-	-32	54	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Hedge ineffectiveness on foreign exchange contracts
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	84	-84	-	-	-	-	-	-	-	-
Stock-based compensation expense
17,769	1,716	2,059	2,229	1,115	-56	2,596	1,261	957	124	939	963	1,112	1,093	1,050	813	786	697	621	226	501	475	410	422	194	313	186	217	156	262	239	232	204	131	249	-43	50	-	-	-	-
Deferred income taxes
129	-	-	-	602	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Tax benefit (expense) from stock-based compensation arrangements
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	2,806	2,827	5,196	1,989
Net excess tax benefit from stock-based compensation
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-23,226	17,777	-5,258	-2,217
Deferred taxes
-	-	-	-	-	17,131	7,991	-12,070	794	10,202	-253	13,902	15,321	-4,663	1,472	730	-8,215	8,108	785	5,015	3,343	-13,349	-3,929	-1,552	-1,012	-336	-115	-272	-276	4,815	1,980	2,582	1,961	6,100	5,694	19,421	2	-	-	-	-
Changes in assets and liabilities:
Deferred income taxes
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-2,449	-3,507	277
Accounts receivable
1,245	620	-5,269	-2,074	-1,472	6,403	-4,043	-3,143	-8,566	13,557	-9,507	-2,617	-12,441	8,085	26,035	0	0	0	-100	400	-300	50	-1,102	-10,298	11,350	-600	900	-150	-216	366	0	0	-600	600	0	-150	-319	219	-1,700	0	900
Increase (Decrease) in Accounts and Other Receivables
-	-	-	-	-	-	-	-	-	-	-	0	-6,000	243	2,876	2,881	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Prepaid and other current assets
14,666	-1,249	-1,568	-599	-1,048	468	-2,259	7,348	-532	4,934	1,466	627	2,073	1,056	-26	66	430	-4,392	3,739	-5,701	6,396	-167	-200	-915	-844	2,911	-2,142	-1,635	479	33	1,314	-5,112	-1,468	2,080	5,326	2,126	-9,333	4,378	-11,278	5,740	-285
Accrued interest on notes receivable
-	-	-	-	-	-230	80	76	74	102	13,686	-15,338	75	19	468	326	1,951	-830	549	-67	2,594	-1,567	-1,798	6,881	3,284	2,957	1,234	2,849	2,490	2,832	0	0	0	-	-	-	-	-	-	-	-
Inventory
3,900	19,136	4,644	-2,645	788	6,037	-2,363	915	4,919	-3,177	462	1,062	761	1,634	1,593	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other assets
0	514	118	-303	-173	315	274	-189	1,720	1,747	-339	8	-16	787	1	-2,470	2,439	900	-12	-12	-11	34	0	29	0	-236	907	-935	0	-1,146	-4	-1,121	2,288	-3	883	5,702	57	-40	-236	47	47
Accounts payable
2,554	4,078	-1,557	1,735	-65	4,132	-2,095	1,261	-9,940	9,445	402	-9,939	10,932	-119	6,061	411	268	-27	-280	86	297	-761	738	-69	123	-1,182	1,354	-389	-570	261	658	-316	-57	643	-239	-162	-2,254	-	-	-	-
Accrued legal settlement
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-27,500	-	0	27,500	-65,000	65,000	0	0	0
Accounts payable
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1,111	-508	315
Accrued liabilities
-238	608	4,707	-15,226	570	1,238	3,072	-5,533	-6,226	-5,860	13,438	598	4,944	11,960	7,023	4,915	-1,169	-187	-759	979	-1,081	1,018	-1,101	1,744	2,682	-2,749	1,592	379	-669	-1,966	930	113	985	-	-	3,610	-2,447	-36,326	12,759	-61	-2,601
Increase (Decrease) in Deferred Revenue
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1,713	-100
Increase (Decrease) in Income Taxes Payable
-	-	-	-	-	-75	-127	-654	-505	-5,778	-7,846	5,692	4,586	-1,069	-4,000	-11,226	17,647	3,372	0	0	-3,293	-3,201	-4,323	5,482	5,335	-3,231	-15,522	18,753	0	-	-	-	-	-	-	-	-	-	-	-	-
Other long-term liabilities
316	4,315	326	195	-28	-1,742	614	259	407	-2,278	10,906	1,024	-10,875	-2,284	2,559	1,168	2,357	2,389	3,836	3,166	3,546	-5,129	3,705	4,609	2,520	3,352	-212	-5,469	198	-283	248	213	-1,711	-	-	-	-	-	-	-	-
Net cash used in operating activities - continuing operations
-15,254	-	-	-	-2,303	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net cash (used in) provided by operating activities - discontinued operations
-3,765	-	-	-	6,818	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net cash provided by operating activities
-	-	-	-	-	-2,066	8,397	-6,235	-13,521	-17,439	-3,549	15,830	45,782	15,653	-8,687	2,246	92,506	70,079	75,486	84,054	71,846	69,042	77,086	78,012	68,141	61,210	45,826	109,854	52,855	53,884	35,829	104,897	17,896	45,146	36,713	101,075	-13,152	29,987	277,940	-150,563	26,936
Cash flows from investing activities
Purchases of investments
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	3,906	19,999	0	5,993	3,047	13,338	10,046	48,313	-	-	-	-
Payments to Acquire Investments
-	-	-	-	-	-	-	-	-	-	3,353	3,885	15,975	-	7,985	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	41,212	-12,402	0
Maturities of investments
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1,682	25,693	4,000	12,405	14,032	16,799	6,000	14,000	11,550	13,000	8,265	17,881	-	-	-	-
Proceeds from Sale of Available-for-sale Securities, Equity
-	-	-	-	-	-	0	1	4,115	-	8,850	13,030	16,015	-	-1	1,408	273	-	1,124	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Payments for (Proceeds from) Productive Assets
-	-	-	-	-	-20,920	-19,056	-19,370	-18,623	-32,849	-26,342	-34,568	-13,494	-25,342	-15,331	-14,688	-17,221	-34,437	-6,879	-1,153	-938	-20,743	-32,266	-25,813	-23,638	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Proceeds from Sale of Productive Assets
-	-	-	-	-	-	-	-	-	0	0	0	108,169	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Issuance of notes receivable
-	-	-	-	-	-	-	-	-	-	-	-	-	1,010	3,000	0	5,000	26,259	3,750	5,226	0	15,000	0	165,000	50,000	100,000	21,404	24,725	2,579	49,326	40,839	0	7,425	-	-	-	-	-	-	-	-
Repayment of notes receivable
-	-	-	-	-	-	-	-	-	48	0	252	7,890	-54,653	54,653	0	0	-	-	-	-	-	-	-	-	0	42,500	7,500	9,279	5,000	0	0	0	-	-	-	-	-	-	-	-
Purchase of property and equipment
93	259	341	121	42	-118	726	2,517	1,398	137	455	171	534	25	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	33	-1	11	8	-	-	-	-	-	-	-	-
Net cash used in investing activities - continuing operations
-93	-	-	-	-42	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net cash provided by investing activities - discontinued operations
13,569	-	-	-	12,620	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Maturities of investments
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	2,000	0	0
Net cash provided by/(used in) investing activities
-	-	-	-	-	20,180	-1,670	16,854	21,340	34,821	251,213	43,794	129,059	12,340	-502	-168,842	12,494	13,643	-90,156	-4,073	938	10,723	32,256	-154,726	-26,362	-339,632	43,289	-19,602	19,105	-34,233	-44,038	5,989	574	8,503	-288	-1,831	-30,432	-10,086	-14,408	-12,402	0
Cash flows from financing activities
Cash payment for repurchase of convertible notes
18,800	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Repayments of Secured Debt
-	-	-	-	-	-	0	0	126,447	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	22,738	46,793	23,839	21,898	26,432	42,259	20,311	-	-	-	-
Net receipts for capped call transactions
-801	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Payments for Repurchase of Convertible Preferred Stock
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	43,010	0	155,050	22,337	26,285	0	0	29,906	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-
Proceeds from term loan
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	100,000	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Repayments of Notes Payable
-	-	-	-	-	-	-	-	-	-	-	-	-	-25,000	0	0	25,000	25,000	25,000	25,000	0	18,750	18,750	18,750	18,750	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-
Payment of debt issuance costs
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	607	538	-537	0	9,824	0	0	0	0	0	0	0	845	-	-	-	-	-	-	-	-
Net proceeds from the issuance of convertible notes
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	300,000	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-
Net receipts for capped call transactions
-	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Payment of contingent consideration
0	0	0	0	1,071	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Repurchase of Company common stock
19,226	11,007	4,625	26,978	44,288	24,109	1,396	20,044	3,560	0	0	22,353	7,647	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Purchase of purchased call options, net of tax
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-30,951	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-
Proceeds from issuance of warrants
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	11,427	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-
Repayment of non-recourse notes
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	125,324	-62,986	12,621
Payments of Dividends
-	-	-	-	-	-	-	-	-	201	0	0	21	150	0	8,200	8,233	24,684	24,540	24,534	24,549	24,422	24,047	24,046	24,042	21,063	20,979	20,984	20,980	21,056	20,962	20,962	20,962	20,952	20,952	20,958	20,966	70,179	119,728	-59,949	85
Net settlement of stock-based compensation awards
-3,462	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	2,622	2,827	5,258	2,217
Net cash used in financing activities - continuing operations
-40,732	-	-	-	-45,359	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net cash used in financing activities - discontinued operations
-359	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net decrease in cash and cash equivalents
-46,634	-	-	-	-28,266	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net cash used in financing activities
-	-	-	-	-	-24,508	-1,396	-20,044	-130,007	-201	-87,007	-24,523	-7,668	12,571	-75	-8,200	-33,233	-92,694	-49,540	-204,584	52,507	-69,995	-42,260	-42,796	197,954	53,128	-20,992	-20,971	-20,980	-21,029	-43,707	-67,748	-45,646	-42,237	-47,315	-57,935	-41,277	-8,813	-27,104	-192,651	-10,489
Net increase/(decrease) in cash and cash equivalents
-	-	-	-	-	-6,394	5,331	-9,425	-122,188	17,181	160,657	35,101	167,173	40,564	-9,264	-174,796	71,767	-8,972	-64,210	-124,603	125,291	9,770	67,082	-119,510	239,733	-225,294	68,123	69,281	50,980	-1,378	-51,916	43,138	-27,176	11,412	-10,890	41,309	-84,861	11,088	-10,826	-108,362	16,447
Supplemental cash flow information
Cash (refunded) paid for income taxes
-26	-4	8	80	-2,773	-214	39	3,336	644	8,246	20,915	14,085	120	0	16,000	12,000	22,000	43,000	41,000	32,000	52,000	55,000	53,000	47,000	34,000	38,000	46,000	27,000	28,000	23,000	46,000	12,000	18,000	17,000	38,000	14,000	14,000	-	-	-	-
Line of Credit Facility, Commitment Fee Amount
-	-	-	-	-	-	-	-	-	-	-	-	-	-	1,545	354	443	-	0	-1,258	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Capital Expenditures Incurred but Not yet Paid
-	-	-	-	-	-	-	-	-	-	-	-	-288	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cash paid for interest
95	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Supplemental disclosures of non-cash financing activities
Assets held for sale reclassified from other assets to intangibles
-	-	-	-	-	0	0	0	1,811	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cash paid for interest
-	-	-	-	-	-	-	2,062	2,529	-	2,529	2,166	2,529	1,480	4,929	0	5,001	942	6,390	3,323	6,332	3,222	6,541	3,222	5,454	2,911	2,588	2,910	2,588	2,911	3,170	4,693	4,980	5,623	6,218	5,715	8,071	-	-	-	-
Other Significant Noncash Transaction, Value of Consideration Given
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	9,794	14,288	0	0	157,591	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-
Assets held for sale reclassified from notes receivable to other assets
-	-	-	-	-	-	-	-	-	-	0	0	10,000	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-